Revenue from Contracts with Customers (Tables)

9 Months Ended

Sep. 30, 2023

Revenue from Contracts with Customer [Abstract]

Schedule of revenues by type of service

The Company provides diagnostic test products and laboratory services to hospitals, clinical laboratories and other healthcare providing customers, and enters into collaboration agreements with government agencies, non-governmental organizations, and healthcare providers. The revenues by type of service consist of the following:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Product sales	$	558,965	$	359,112	$	1,409,534	$	1,614,435
Laboratory services		47,135		31,016		112,810		94,515
Collaboration revenue		92,922		58,585		826,257		176,713
Total revenue	$	699,022	$	448,713	$	2,348,601	$	1,885,663

Schedule of revenues by geography

Revenues by geography are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Domestic	$	142,716	$	135,857	$	523,978	$	415,926
International		556,306		312,856		1,824,623		1,469,737
Total revenue	$	699,022	$	448,713	$	2,348,601	$	1,885,663

Schedule of changes in deferred revenue

Changes to deferred revenue for the period were as follows:

Balance at December 31, 2022	$	142,061
Contracts with customers		198,419
Recognized in the current period		(144,031	)
Currency translation adjustment		(1,762	)
Balance at September 30, 2023	$	194,687